COMPARISON OF EXPRESSION OF E-CADHERIN IN ORAL PSEUDOEPITHELIOMATOUS HYPERPLASIA AND ORAL SQUAMOUS CELL CARCINOMA

Ayesha Mukhtar Awan; Iram Naz; Muhammad Khurram Mahmood; Hafeez Uddin

doi:10.46903/gjms/17.03.1967

COMPARISON OF EXPRESSION OF E-CADHERIN IN ORAL PSEUDOEPITHELIOMATOUS HYPERPLASIA AND ORAL SQUAMOUS CELL CARCINOMA

Ayesha Mukhtar Awan, Iram Naz, Muhammad Khurram Mahmood, Hafeez Uddin

Abstract

Background: Pseudo-epitheliomatous Hyperplasia (PEH) is a benign proliferation of epithelium occurring in response to various neoplastic lesions, infections and inflammatory processes. It can be mistaken especially in small biopsies for an invasive oral squamous cell carcinoma (OSCC). The objective of this study was to determine the expression and comparison of immunohistochemical marker E-cadherin in OSCC and PEH lesions.

Materials & Methods: This cross-sectional study was conducted in Department of Histopathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan from January 2013 to March 2016. 60 paraffin embedded cases, 30 each of PEH and OSCC were retrieved and stained with haematoxylin and eosin. They were then immune-stained with E-cadherin and expression evaluated and compared in two lesions by histopathologist. Age, sex, site of lesion and E-cadherin expression were variables. Age was described by mean and SD and other variables as frequency and percentages.

Results: Mean age of OSCC group was 60.1±17.3 years and PEH group 52.7±16.6 years. OSCC group included 16 (53.33%) men and 14 (46.67%) women. PEH group included 18 (60%) men and 12 (40%) women. In OSCC group, site of lesion was buccal mucosa 12 (40%) cases, gingiva 10 (33.3%), tongue 7 (23.3%) and floor of mouth 1 (3.4%) case. In PEH group, site of lesion was buccal mucosa 12 (40%) cases, tongue 11 (36.67%), gingiva 6 (20%) and palate 1 (3.3%) case. The expression of E-cadherin was negative in all 30 cases of OSCC and positive in 29/30 (96.67%) cases in PEH.

Conclusion: E-cadherin can be used as an ancillary marker in the differentiation of oral squamous cell carcinoma and pseudo-epitheliomatous hyperplasia.

Keywords

Pseudo-epitheliomatous Hyperplasia; Squamous cell carcinoma; E-Cadherins; Immunohistochemistry; Cancer biomarkers; Monoclonal antibodies.

Full Text:

PDF

References

Patel S, Ansari J, Meram A, Abdulsattar J, Cotelingam J, Coppola D, et al. Increased nicotinamide phosphoribosyl transferase and cystathionine-beta-synthase in oral cavity squamous cell carcinomas. Int J Clin Exp Pathol 2017; 10(1):702-7.

Shaikh AH, Mohammad T, Qureshi NR. Histopathological patterns of oral squamous cell carcinoma. Pak Oral Dental J 2014; 34(3):449-51.

Krishna A, Singh RK, Singh S, Verma P, Pal US, Tiwari S. Demographic risk factors, affected anatomical sites and clinicopathological profile for oral squamous cell carcinoma in a north Indian population. Asian Pac J Cancer Prev 2014; 15(16):6755-60. https://doi.org/10.7314/APJCP.2014.15.16.6755

Singh MP, Kumar V, Agarwal A, Kumar R, Bhatt ML, Misra S. Clinico-epidemiological study of oral squamous cell carcinoma: A tertiary care centre study in North India. J Oral Biol Craniofac Res 2016; 6(1):32-5. https://doi.org/10.1016/j.jobcr.2015.11.002

Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J 2012; 6:126-30. https://doi.org/10.2174/1874210601206010126

Athirajan V, Razak IA, Thurairajah N, Ghani WM, Ching HN, Yi HY, et al. High serum level of retinol and alpha-tocopherol affords protection against oral cancer in a multiethnic population. Asian Pac J Cancer Prev 2014; 15(19):8183-9. https://doi.org/10.7314/APJCP.2014.15.19.8183

Li G, Li X, Yang M, Xu L, Deng S, Ran L. Prediction of biomarkers of oral squamous cell carcinoma using microarray technology. Sci Rep 2017; 7:1-8. https://doi.org/10.1038/srep42105

Eid RA, Sawair F, Landini G, Saku T. Age and the architecture of oral mucosa. AGE 2012; 34(3):651-8. https://doi.org/10.1007/s11357-011-9261-1

Chakrabarti S, Chakrabarti PR, Agrawal D, Somanath S. Pseudoepitheliomatous hyperplasia: A clinical entity mistaken for squamous cell carcinoma. J Cutan Aesthet Surg 2014; 7(4):232-34. https://doi.org/10.4103/0974-2077.150787

Mehendiratta M, Solomon MC, Boaz K, Guddattu V, Mohindra A. Clinico-pathological correlation of E-cadherin expression at the invasive tumor front of Indian oral squamous cell carcinomas: An immunohistochemical study. J Oral Maxillofac Pathol 2014; 18(2):217-22. https://doi.org/10.4103/0973-029X.140753

Ahmad M, Khadim M, Bukhari N. E-cadherin expression, a valuable predictor of invasiveness in histological grades of oral squamous cell carcinoma. Pak Oral Dental J 2013; 33(2):271-7.

Zarovnaya E, Black C. Distinguishing pseudoepitheliomatous hyperplasia from squamous cell carcinoma in mucosal biopsy specimens from the head and neck. Arch Pathol Lab Med 2005; 129(8):1032-6.

Bhargava A, Saigal S, Chalishazar M. Histopathological grading systems in oral squamous cell carcinoma: A review. J Int Oral Health 2010; 2(4):1-10.

You TK, Kim KM, Noh SJ, Bae JS, Jang KY, Chung MJ, et al. Expressions of E-cadherin, Cortactin and MMP-9 in pseudoepitheliomatous hyperplasia and squamous cell carcinoma of the head and neck: Their relationships with clinicopathologic factors and prognostic implication. Korean J Pathol 2012 Aug; 46(4):331-40. https://doi.org/10.4132/KoreanJPathol.2012.46.4.331

Hu Y, He MY, Zhu LF, Yang CC, Zhou ML, Wang Q, et al. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma. J Exp Clin Canc Res 2016; 35:1-19. https://doi.org/10.1186/s13046-015-0281-z

Ling YH, Zhu CM, Wen SH, Luo RZ, Li P, Cao Y, et al. Pseudoepitheliomatous hyperplasia mimicking invasive squamous cell carcinoma in extranodal natural killer/T-cell lymphoma: a report of 34 cases. Histopathology 2015; 67(3):404-9. https://doi.org/10.1111/his.12656

de Moraes M, Monteiro Maia CAD, de Almeida Freitas R, Galvao HC. Cell proliferation markers in oral squamous cell carcinoma. J Mol Biomark Diagn 2012; 2:1-5. S2:006. https://doi.org/10.4172/2155-9929.S2-006

Rajwar YC, Jain N, Bhatia G, Sikka N, Garg B, Walia E. Expression and significance of cadherins and its subtypes in development and progression of oral cancers: a review. J Clin Diagn Res 2015; 9(5):ZE05-7. https://doi.org/10.7860/JCDR/2015/11964.5907

Zaid KW. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma. Asian Pac J Cancer Prev 2014; 15(20):8847-53. https://doi.org/10.7314/APJCP.2014.15.20.8847

Sridevi U, Jain A, Nagalaxmi V, Kumar UV, Goyal S. Expression of E-cadherin in normal oral mucosa, in oral precancerous lesions and in oral carcinomas. Eur J Dent 2015; 9(3):364-72. https://doi.org/10.4103/1305-7456.163238

Liu LK, Jiang XY, Zhou XX, Wang DM, Song XL, Jiang HB. Upregulation of vimentin and aberrant expression of E-cadherin/ β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol 2010; 23(2):213-24. https://doi.org/10.1038/modpathol.2009.160

Yuwanati MB, Tupkari JV, Avadhani A. Expression of E-cadherin in oral epithelial dysplasia and oral squamous cell carcinoma: An in vivo study. J Clin Exp Invest 2011; 2(4):347-53. https://doi.org/10.5799/ahinjs.01.2011.04.0070

DOI: https://doi.org/10.46903/gjms/17.03.1967